New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Molecular Partners AG
MOLN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

157M

Biotechnology

Next Earning date - 15 May 2025

157M

Biotechnology

Next Earning date - 15 May 2025

4.25USD

Shape0.06 ( 1.43%)
sun-fogPre-market 4.95$arrow-right-up0.04 (0.72%)
Market Closed (as of Mar 20, 20:00 EDT)
favorite-chart

Relative Strenght

22
favorite-chart

Volume Buzz

-67%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated March 21, 2025
1W -0.70 % 1M -13.27 % 3M -21.88 % 1Y 4.42 %

Key Metrics

Shape
  • Market Cap

    156.72M


  • Shares Outstanding

    36.87M


  • Share in Float

    36.77M


  • Dividende

    0


  • Earning Date

    15 May 2025


  • Price Target

    4.25


  • Average Volume

    3655


  • Beta

    0.629


  • Range

    3.32-12.7


  • Industry

    Biotechnology


  • Website

    https://www.molecularpartners.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

MOLN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

ShapeNaN%

2025-Revenue

$1.60

Shape-370%

2025-EPS

$2M

Shape86%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Credit Suisse

downgrade

Previous: Not converted

2022-04-27

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.49
vs 4.62

Q2.23

arrow
arrow

N/A

-0.55
vs -0.15

Q3.23

arrow
arrow

N/A

-0.40
vs -0.42

Q4.23

arrow
arrow

N/A

-0.68
vs -0.56

Q1.24

arrow
arrow

N/A

-0.39
vs -0.49

Q2.24

arrow
arrow

N/A

-0.51
vs -0.55

Q3.24

arrow
arrow

N/A

-0.57
vs -0.40

Q4.24

arrow
arrow

N/A

-0.34
vs -0.68

Q1.25

arrow
arrow

N/A

-0.38
vs -0.39

Q2.25

arrow
arrow

N/A

-0.39
vs -0.51

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-34%

2.3M  vs 3.5M

Q4.22

arrow
arrow

+52%

2.7M  vs 1.8M

Q1.23

arrow
arrow

-98%

3M  vs 172.8M

Q2.23

arrow
arrow

-96%

415K  vs 11.7M

Q3.23

arrow
arrow

+9%

2.5M  vs 2.3M

Q4.23

arrow
arrow

-62%

1M  vs 2.7M

Q1.24

arrow
arrow

-10%

2.7M  vs 3M

Q2.24

arrow
arrow

+274%

1.6M  vs 415K

Q3.24

arrow
arrow

-73%

681K  vs 2.5M

Q4.24

arrow
arrow

-100%

NA  vs 1M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-7%

-0.07
vs -0.09

Q2.23

arrow
arrow

-8%

-0.08
vs -0.07

Q3.23

arrow
arrow

-6%

-0.06
vs -0.08

Q4.23

arrow
arrow

-11%

-0.11
vs -0.06

Q1.24

arrow
arrow

-7%

-0.07
vs -0.11

Q2.24

arrow
arrow

-10%

-0.10
vs -0.07

Q3.24

arrow
arrow

-12%

-0.12
vs -0.10

Q4.24

arrow
arrow

-8%

-0.08
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

6

6
vs 9

-33%

Q2.23

arrow
arrow

7

7
vs 6

17%

Q3.23

arrow
arrow

7

7
vs 7

NA

Q4.23

arrow
arrow

8

8
vs 7

14%

Q1.24

arrow
arrow

8

8
vs 8

NA

Q2.24

arrow
arrow

8

8
vs 8

NA

Q3.24

arrow
arrow

5

5
vs 8

-37%

Q4.24

arrow
arrow

5

5
vs 5

NA

Earnings Growth

Latest News